MINGARI, MARIA CRISTINA
 Distribuzione geografica
Continente #
EU - Europa 38.418
AS - Asia 3.570
NA - Nord America 1.958
SA - Sud America 275
AF - Africa 54
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 44.278
Nazione #
IT - Italia 37.744
US - Stati Uniti d'America 1.848
SG - Singapore 1.567
CN - Cina 957
VN - Vietnam 600
FR - Francia 297
BR - Brasile 169
HK - Hong Kong 134
FI - Finlandia 126
BD - Bangladesh 82
DE - Germania 74
AR - Argentina 51
JP - Giappone 51
CA - Canada 46
CH - Svizzera 41
GB - Regno Unito 38
MX - Messico 30
IN - India 26
RU - Federazione Russa 21
ID - Indonesia 19
IQ - Iraq 19
NL - Olanda 17
ZA - Sudafrica 14
CO - Colombia 13
PH - Filippine 12
PL - Polonia 12
SA - Arabia Saudita 12
PK - Pakistan 10
JM - Giamaica 9
JO - Giordania 9
TH - Thailandia 9
VE - Venezuela 9
EC - Ecuador 8
TW - Taiwan 8
CL - Cile 7
CR - Costa Rica 7
DZ - Algeria 7
IE - Irlanda 7
MA - Marocco 6
PE - Perù 6
PY - Paraguay 6
TR - Turchia 6
ES - Italia 5
KE - Kenya 5
LB - Libano 5
MY - Malesia 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
EG - Egitto 4
HN - Honduras 4
NP - Nepal 4
SE - Svezia 4
UA - Ucraina 4
AO - Angola 3
BB - Barbados 3
CG - Congo 3
DO - Repubblica Dominicana 3
GE - Georgia 3
GT - Guatemala 3
KR - Corea 3
LT - Lituania 3
RS - Serbia 3
AL - Albania 2
BG - Bulgaria 2
BO - Bolivia 2
ET - Etiopia 2
IL - Israele 2
IR - Iran 2
KZ - Kazakistan 2
MK - Macedonia 2
MM - Myanmar 2
NG - Nigeria 2
NI - Nicaragua 2
OM - Oman 2
PS - Palestinian Territory 2
TN - Tunisia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
CD - Congo 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
DJ - Gibuti 1
GA - Gabon 1
GF - Guiana Francese 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
KH - Cambogia 1
KW - Kuwait 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
MT - Malta 1
NO - Norvegia 1
Totale 44.267
Città #
Genova 24.564
Genoa 7.707
Rapallo 2.949
Vado Ligure 2.348
Singapore 706
San Jose 704
Lauterbourg 284
Ashburn 249
Ho Chi Minh City 177
Beijing 138
Hanoi 131
Hong Kong 126
Helsinki 125
New York 116
Council Bluffs 89
Santa Clara 66
Frankfurt am Main 60
Bordighera 52
Tokyo 50
Zurich 41
Haiphong 35
Tianjin 29
Los Angeles 23
Shanghai 21
Orem 19
Da Nang 17
Mexico City 16
Duarte 15
Chicago 14
Milan 14
Atlanta 13
Biên Hòa 13
São Paulo 13
Amsterdam 11
Hải Dương 10
Montreal 10
Phoenix 10
Toronto 10
Amman 9
Baghdad 9
Boardman 9
Des Moines 9
Rome 9
Chennai 8
City of London 8
Buffalo 7
Can Tho 7
Hưng Yên 7
Johannesburg 7
London 7
Nuremberg 7
Paris 7
Warsaw 7
Dallas 6
Dublin 6
Guangzhou 6
Lima 6
Naples 6
Ninh Bình 6
Thái Nguyên 6
Bangkok 5
Cardiff 5
Cleveland 5
Curitiba 5
Hangzhou 5
Houston 5
Moscow 5
Nha Trang 5
Poplar 5
Quận Ba 5
San José 5
Shenyang 5
Shenzhen 5
Thái Bình 5
Bogotá 4
Campinas 4
Cape Town 4
Charlotte 4
Denver 4
Duque de Caxias 4
Fortaleza 4
Guayaquil 4
Ha Long 4
Jeddah 4
Kansas City 4
Kingston 4
Las Vegas 4
Long Xuyen 4
Maracaibo 4
Mumbai 4
Nairobi 4
Phủ Lý 4
Pisa 4
Quảng Ngãi 4
Ribeirão Preto 4
Rio de Janeiro 4
Riyadh 4
Scandicci 4
Vinh 4
Abu Dhabi 3
Totale 41.307
Nome #
Mesenchymal stem cell-Natural Killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. 448
Identification of cytomegalovirus (CMV)-specific T lymphocytes displaying an effector-memory phenotype that kill CMV-infected target cells in an HLA-E-restricted fashion 255
Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function 254
PVR(CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis 237
Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112) 223
Internalization via Antennapedia protein transduction domain of an scFv antibody toward c-Myc protein 219
Unique Eomes+ NK cell subsets are present in uterus and decidua during early pregnancy 219
Human NK cells at early stages of differentiation produce large amounts of CXCL8 and express CD161 molecule that that functions as an activating receptor 215
Cytokines can counteract the inhibitory effect of MEK-i on NK-cell function 214
Role of the calpain-calpastatin system in the density-dependent growth arrest 209
T cell nature of some lymphokine-activated killer (LAK) cells. Frequency analysis of LAK precursors within human T cell populations and clonal analysis of LAK effector cells. 207
A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation 203
NK-cell editing mediates epithelial-to-mesenchymal transition via phenotypic and proteomic changes in melanoma cell lines 200
B cell growth factor activity of immunoaffinity-purified and recombinant human interleukin 2. 193
Human NK cell receptors/markers: A tool to analyze NK cell development, subsets and function. 193
Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment 193
NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation. 192
Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages 191
Effect of tumor cells and tumor microenvironment on NK-cell function. 191
Characterization of the calpain/calpastatin system in human hemopoietic cell lines 191
Anticorpo ricombinante umano e suo uso per l’ identificazione del sindecano-1 a scopo diagnostico e terapeutico 189
Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias 189
IL-1β inhibits ILC3 while favoring NK-cell maturation of umbilical cord blood CD34(+) precursors 187
Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK cell function 186
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. 186
NCR + ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures 185
Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression 185
Human innate lymphoid cells 183
CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells. 182
Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2 181
Analysis of NK cell/DC interaction in NK-type lymphoproliferative disease of granular lymphocytes (LDGL): role of DNAM-1 and NK p30 181
Markers and function of human NK cells in normal and pathological conditions 179
Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts 177
Human NK Cells: From Surface Receptors to the Therapy of Leukemias and Solid Tumors. 177
Evaluation of Glycosylated PTGS2 in Colorectal Cancer for NSAIDS-Based Adjuvant Therapy 177
Phenotypic and functional analysis of the HLA-class I-specific inhibitory receptors of natural killer cells isolated from peripheral blood of patients undergoing bone marrow transplantation from matched unrelated donors. 176
Methylprednisolone induces preferential and rapid differentiation of CD34+ cord blood precursors toward NK cells. 176
4F2 monoclonal antibody recognizes a surface antigen on spread human fibroblasts of embryonic but not of adult origin. 176
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy? 176
"Physiological and Pathological Aspects of Human NK Cells" 173
Surface antigens specifically expressed by activated T cells in humans. 173
Human NK receptors: from the molecules to the therapy of high risk leukemias. 173
Characterization of human afferent lymph dendritic cells from seroma fluids. 173
Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition 172
In vitro proliferation and cloning of CD3- CD16+ cells from human thymocyte precursors. 170
Diagnosing XLP1 in patients with hemophagocytic lymphohistiocytosis. 170
MSC and innate immune cell interactions: A lesson from human decidua 170
Generation of a novel regulatory NK cell subset from peripheral blood CD34+ progenitors promoted by membrane-bound IL-15. 170
Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response. 170
Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer 169
Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor 169
Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation. 168
HO-1 downregulation favors BRAFV600 melanoma cell death induced by Vemurafenib/PLX4032 and increases NK recognition 168
NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs 167
Development of human natural killer cells and other innate lymphoid cells. 167
Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias: Engagement of CD33 induces apoptosis of leukemic cells 167
CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph. 167
Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. 166
Stimulatory receptors in NK and T cells. 166
Cytolytic T lymphocytes displaying Natural Killer (NK)-like activity. Expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production 166
Analysis of the circulating Th1/Th17 lymphocyte repertoire after hematopoietic stem cell transplant may reveal opportunistic fungal infections rather than GvHD reaction 166
NK Cells and Other Innate Lymphoid Cells in Hematopoietic Stem Cell Transplantation 166
Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis 165
In vivo generation of decidual Natural Killer cells from resident hematopoietic progenitors. 165
Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients 164
Effect of superantigens on human thymocytes: selective proliferation of V beta 2+ cells in response to toxic shock syndrome toxin-1 and their deletion upon secondary stimulation 163
T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. 163
Surface receptors that regulate the NK cell function: beyond the NK cell scope. 161
Regulation of myeloid cell proliferation and survival by p75/AIRM1 and CD33 surface receptors. 160
Dendritic cells efficiently cross-prime HLA class I restricted cytolytic T lymphocytes when pulsed with both apoptotic and necrotic cells but not with soluble cell-derived lysates. 159
IL15 induces a potent antitumor activity in NK cells isolated from malignant pleural effusions and overcomes the inhibitory effect of pleural fluid 159
Il-1β-Releasing human acute myeloid leukemia blasts modulate natural killer cell differentiation from cd34+ precursors 158
Stromal cells from human decidua exert a strong inhibitory effect on NK cell function and dendritic cell differentiation 157
Effect of tyrosin kinase inhibitors on NK Cell and ILC3 development and function 157
Comparative analysis of NK- or NK-CTL-mediated lysis of immature or mature autologous dendritic cells 156
Expression of HLA class I-specific inhibitory receptors in human cytolytic T lymphocytes: a regulated mechanism that controls T-cell activation and function. 155
HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. 155
Surface markers of cloned human T cells with helper or suppressor activity on pokeweed mitogen-driven B cell differentiation. 155
A conserved energetic footprint underpins recognition of Human Leukocyte Antigen-E by two distinct αβ T cell receptors 154
Immunobiology of human NK cells. 153
Surface receptors and functional interactions of human natural killer cells: from bench to the clinic 153
Immune response in the conjunctival epithelium of patients with dry eye. 153
HLA-class I-specific inhibitory receptors of NK type on a subset of human T cells. 153
Inhibitory 2B4 contributes to NK cell education and immunological derangements in XLP1 patients 153
Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells 153
Origin, phenotype and function of human natural killer cells in pregnancy. 152
Analysis of the activating receptors and cytolytic function of human Natural Killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation 151
Anticlonotypic monoclonal antibodies induce proliferation of clonotype-positive T cells in peripheral blood human T lymphocytes. Evidence for a phenotypic (T4/T8) heterogeneity of the clonotype-positive proliferating cells. 151
Understanding human NK cell differentiation: clues for improving the haploidentical hematopoietic stem cell transplantation. 151
Human RORγt(+)CD34(+) Cells Are Lineage-Specified Progenitors of Group 3 RORγt(+) Innate Lymphoid Cells. 151
Role of Ia Antigens in the human autologous mixed lymphocyte reaction. 150
The generation of human innate lymphoid cells is influenced by the source of hematopoietic stem cells and by the use of G-CSF 150
HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes. 150
Unsung hero Robert C. Gallo 150
Human natural killer cells and other innate lymphoid cells in cancer: Friends or foes? 150
Expression of HLA-class I-specific inhibitory Natural Killer cell receptors in HIV-specific cytolytic T lymphocytes. Impairment of specific cytolytic functions. 149
Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab 149
Distinctive lack of CD48 expression in subsets of human dendritic cells tunes NK cell activation. 148
Surface markers of resting and activated human T cells. Functional implications and experimental limits. 147
A new mechanism of resistance to NK cell attack in melanoma 147
Totale 17.651
Categoria #
all - tutte 136.481
article - articoli 131.582
book - libri 0
conference - conferenze 2.052
curatela - curatele 0
other - altro 0
patent - brevetti 760
selected - selezionate 0
volume - volumi 2.087
Totale 272.962


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021209 0 0 0 0 0 0 0 0 0 0 0 209
2021/20224.034 129 283 374 399 202 205 243 962 165 392 172 508
2022/20233.533 375 227 63 324 569 697 2 266 602 13 352 43
2023/20241.857 118 248 49 251 174 336 73 88 125 45 95 255
2024/20255.412 99 431 193 338 884 549 498 785 222 256 464 693
2025/20268.946 1.058 213 504 721 1.261 1.024 1.655 452 606 868 385 199
Totale 44.744